Clinical Trial Update: Safety and Immunogenicity of JECEVAX in Young Children [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and immunogenicity of JECEVAX in young children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• JECEVAX

Snippet

Sponsor: National Institute of Hygiene and Epidemiology, Vietnam | Conditions: Japanese Encephalitis | Phase 2 | Status: COMPLETED